PA-SYNERGIS-SOFTWARE
24.3.2022 13:23:11 CET | Business Wire | Press release
Synergis Software , a global leader in engineering document management and workflow solutions, announced today that Synergis Adept was named as a Leader in the Enterprise Content Management and Product Data Management categories in the G2 Spring 2022 Grid® Reports. G2 is a peer-to-peer business software review website that helps companies choose the best tools for their business. Products in the Leader quadrant are rated highly by verified users of the software product and have significant market presence scores.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220324005238/en/
According to G2’s 2022 Spring Reports, Adept software earned 18 G2 Badges with top placements for “Best Usability”, “Fastest Implementation”, “Ease of Setup”, “Ease of Admin”, and “Highest User Adoption”, and grade the company as “Easiest to do Business With” and “Best Support”—recognition Synergis has received consistently over the past seven quarters.
“These achievements reflect the experience we deliver with our software and the relationships we build with some of the world’s best companies,” says Scott Lamond, vice president of marketing at Synergis Software. “Delivering value in ways that are meaningful to our customers is our top priority, so the G2 results really matter to us. Our customers range from small to very large across varied industries , and they’re all part of the Synergis family. We’re grateful for their trust and inspired to bring them even greater value as we grow together.”
G2 highlights the value of Adept engineering document management software across three categories: Enterprise Content Management, Product Data Management, and Construction Drawing Management. G2 Spring 2022 badges include:
- Leader Enterprise Content Management (ECM)
- Leader Product Data Management (PDM)
- Momentum Leader Enterprise Content Management (ECM)
- Momentum Leader Product Data Management (PDM)
- High Performer Mid-Market Enterprise Content Management (ECM)
- High Performer Mid-Market Product Data Management (PDM)
- High Performer Construction Management
- High Performer Construction Drawing Management
- Best Relationship
- Best Support
- Best Support Small-Business
- Easiest To Do Business With Mid-Market
- Easiest To Do Business With
- Easiest To Do Business With Small-Business
- Fastest Implementation
- Highest User Adoption
- Most Implementable
- Best Usability
The G2 reports are based on direct customer feedback combined with G2’s unique algorithm that calculates customer satisfaction and market presence scores in real-time.
For more details about Adept in the G2 Spring 2022 Reports, visit our website .
Quotes from Verified Users about Synergis Adept
“Adept manages billions of dollars of digital assets containing priceless Dow intellectual property, with thousands of users across several dozen global sites."
Teresa Yang, Product Manager, Document Management, Dow Chemical
“No other software company anywhere works as closely with their customers. The staff is incredibly responsive and consistently goes above and beyond to solve customer issues. For a system your business cannot operate without, this is invaluable.”
Ryan Mongeau, Director of Technology, Space Age Electronics
“Adept has improved our efficiency/processes by 200%. What once took hours in the old systems, I can do in minutes. It’s a very powerful system with unlimited possibilities for adding more useful information for future projects. And the Helpdesk team can tackle and/or resolve any issue I bring to them to improve or streamline our processes.”
Milias H, The Folger Company, Document Control Service Provider
About Synergis Software
Synergis Software is a global leader in document management and workflow solutions and is the creator of Synergis Adept software. Adept serves more than 120,000 users across dozens of industries providing fast, centralized access to design and business documents in a secure, collaborative environment. Adept Integrator connects your enterprise applications so your data and business processes flow seamlessly across your entire IT infrastructure.
Named the customer service leader in the global engineering information management market by Frost & Sullivan and ranked in the Top 5 globally by Helpdesk International for three consecutive years, our commitment to clients is unwavering.
Founded in 1985, Synergis Technologies, LLC is headquartered in Bucks County, PA and is privately owned and funded.
Adept has been battle tested by engineers for over 30 years with customers such as Dow Chemical, Con Edison, General Mills, Merck, NASA, and Nucor Steel.
About G2 Crowd
G2 is the world’s largest tech marketplace where businesses can discover, review, and manage the technology they need to reach their potential. Today, more than 3M people visit G2 to read and write authentic reviews about thousands of software products and professional services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005238/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
